- Report
- October 2023
- 80 Pages
Argentina
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2023
- 100 Pages
Africa
From €1909EUR$2,000USD£1,599GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
France
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
North America
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
China
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Germany
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
India
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Japan
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
United States
From €907EUR$950USD£760GBP

The Autoinjector market is a subset of the Infusions and Injectables market, which includes a variety of medical devices used to deliver drugs and other substances into the body. Autoinjectors are a type of self-injection device that are designed to be used by patients or caregivers to deliver a pre-measured dose of medication. They are typically used to deliver medications such as insulin, epinephrine, and other biologics. Autoinjectors are designed to be easy to use and provide a safe and accurate way to deliver medication.
Autoinjectors are becoming increasingly popular due to their convenience and safety. They are often used in the home setting, allowing patients to self-administer medications without the need for a healthcare professional. This has led to increased demand for autoinjectors, as well as the development of new and improved devices.
Some companies in the Autoinjector market include Becton Dickinson, Eli Lilly, Novo Nordisk, Sanofi, and Ypsomed. Show Less Read more